[go: up one dir, main page]

WO1998016265B1 - Agents embolisants liquides contenant de l'acetate de polyvinyle partiellement hydrolyse - Google Patents

Agents embolisants liquides contenant de l'acetate de polyvinyle partiellement hydrolyse

Info

Publication number
WO1998016265B1
WO1998016265B1 PCT/US1997/018582 US9718582W WO9816265B1 WO 1998016265 B1 WO1998016265 B1 WO 1998016265B1 US 9718582 W US9718582 W US 9718582W WO 9816265 B1 WO9816265 B1 WO 9816265B1
Authority
WO
WIPO (PCT)
Prior art keywords
occludant
new
precursor composition
partially hydrolyzed
radio
Prior art date
Application number
PCT/US1997/018582
Other languages
English (en)
Other versions
WO1998016265A1 (fr
Filing date
Publication date
Priority claimed from US08/734,442 external-priority patent/US5925683A/en
Application filed filed Critical
Priority to JP51855298A priority Critical patent/JP3804071B2/ja
Priority to AU49842/97A priority patent/AU4984297A/en
Priority to DE69735534T priority patent/DE69735534T2/de
Priority to EP97912731A priority patent/EP0934086B1/fr
Publication of WO1998016265A1 publication Critical patent/WO1998016265A1/fr
Publication of WO1998016265B1 publication Critical patent/WO1998016265B1/fr
Priority to US09/291,853 priority patent/US6160025A/en

Links

Abstract

L'invention porte sur une composition de matières comportant des solutions partiellement hydrolysées d'acétate de polyvinyle pouvant servir de précurseur d'un agent embolisant. L'invention porte également sur une procédure d'introduction de solutions dans le corps humain pour former par précipitation des blocs d'occlusion embolisants. Elle porte en outre sur une procédure de traitement des tumeurs hépatiques par embolisation de la veine porte.
PCT/US1997/018582 1996-10-17 1997-10-15 Agents embolisants liquides contenant de l'acetate de polyvinyle partiellement hydrolyse WO1998016265A1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP51855298A JP3804071B2 (ja) 1996-10-17 1997-10-15 部分的に加水分解されたポリビニルアセテートを含有する液体塞栓剤
AU49842/97A AU4984297A (en) 1996-10-17 1997-10-15 Liquid embolic agents containing partially hydrolyzed polyvinyl acetate
DE69735534T DE69735534T2 (de) 1996-10-17 1997-10-15 Flüssige embolisationsmittel aus teilweise hydrolysiertem polyvinylacetat
EP97912731A EP0934086B1 (fr) 1996-10-17 1997-10-15 Agents embolisants liquides contenant de l'acetate de polyvinyle partiellement hydrolyse
US09/291,853 US6160025A (en) 1996-10-17 1999-04-14 Liquid embolic agents

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/734,442 1996-10-17
US08/734,442 US5925683A (en) 1996-10-17 1996-10-17 Liquid embolic agents

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US08/734,442 Continuation-In-Part US5925683A (en) 1996-10-17 1996-10-17 Liquid embolic agents

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US09/291,853 Continuation US6160025A (en) 1996-10-17 1999-04-14 Liquid embolic agents

Publications (2)

Publication Number Publication Date
WO1998016265A1 WO1998016265A1 (fr) 1998-04-23
WO1998016265B1 true WO1998016265B1 (fr) 1998-06-18

Family

ID=24951721

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1997/018582 WO1998016265A1 (fr) 1996-10-17 1997-10-15 Agents embolisants liquides contenant de l'acetate de polyvinyle partiellement hydrolyse

Country Status (6)

Country Link
US (2) US5925683A (fr)
EP (1) EP0934086B1 (fr)
JP (1) JP3804071B2 (fr)
AU (1) AU4984297A (fr)
DE (1) DE69735534T2 (fr)
WO (1) WO1998016265A1 (fr)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6063070A (en) 1997-08-05 2000-05-16 Target Therapeutics, Inc. Detachable aneurysm neck bridge (II)
WO1999008607A1 (fr) 1997-08-05 1999-02-25 Boston Scientific Limited Pont detachable de collet d'anevrisme
US6511468B1 (en) 1997-10-17 2003-01-28 Micro Therapeutics, Inc. Device and method for controlling injection of liquid embolic composition
US6146373A (en) * 1997-10-17 2000-11-14 Micro Therapeutics, Inc. Catheter system and method for injection of a liquid embolic composition and a solidification agent
EP1109499B1 (fr) 1998-09-04 2007-08-15 Boston Scientific Limited Piece de fermeture detachable pour collet anevrysmal
FR2784580B1 (fr) 1998-10-16 2004-06-25 Biosepra Inc Microspheres de polyvinyl-alcool et procedes de fabrication de celles-ci
WO2001003666A2 (fr) * 1999-07-12 2001-01-18 Scimed Life Systems, Inc. Compositions pour occlusion vasculaire a base de liquide
US6346098B1 (en) 2000-03-07 2002-02-12 The Board Of Trustees Of The Leland Stanford Junior University Methods and kits for locally administering an active agent to an interstitial space of a host
JP4871476B2 (ja) 2000-03-13 2012-02-08 バイオコンパティブルズ ユーケー リミテッド 塞栓組成物
EP1820495B1 (fr) 2000-03-24 2017-03-01 Biosphere Medical, Inc. Microsphères pour embolisation active
US20030212022A1 (en) * 2001-03-23 2003-11-13 Jean-Marie Vogel Compositions and methods for gene therapy
US6729356B1 (en) 2000-04-27 2004-05-04 Endovascular Technologies, Inc. Endovascular graft for providing a seal with vasculature
US6658288B1 (en) 2000-05-05 2003-12-02 Endovascular Technologies, Inc. Apparatus and method for aiding thrombosis through the application of electric potential
ATE344677T1 (de) * 2000-08-02 2006-11-15 Aesculap Ag & Co Kg Medizintechnisches produkt, verfahren zu seiner herstellung und bereitstellung für die chirurgie
DE10117099A1 (de) * 2000-08-02 2002-02-21 Aesculap Ag & Co Kg Medizintechnisches Produkt, Verfahren zu seiner Herstellung und Bereitstellung für die Chirurgie
AU2002303464A1 (en) * 2001-04-26 2002-11-11 Christopher H. Porter Method and apparatus for delivering materials to the body
EP1392182A1 (fr) * 2001-05-04 2004-03-03 Concentric Medical Dispositif vaso-occlusif a base d'hydrogel
WO2002089865A2 (fr) * 2001-05-04 2002-11-14 Concentric Medical Dispositif revetu d'une composition d'occlusion vasculaire
US20020193813A1 (en) * 2001-05-04 2002-12-19 Concentric Medical Hydrogel filament vaso-occlusive device
US6685745B2 (en) 2001-05-15 2004-02-03 Scimed Life Systems, Inc. Delivering an agent to a patient's body
US7687053B2 (en) 2001-08-20 2010-03-30 Boston Scientific Scimed, Inc. Embolic compositions with non-cyanoacrylate rheology modifying agents
US20030050635A1 (en) * 2001-08-22 2003-03-13 Csaba Truckai Embolization systems and techniques for treating tumors
US6911219B2 (en) * 2001-09-27 2005-06-28 Surgica Corporation Partially acetalized polyvinyl alcohol embolization particles, compositions containing those particles and methods of making and using them
US20030093111A1 (en) * 2001-10-26 2003-05-15 Concentric Medical Device for vaso-occlusion and interventional therapy
US7341716B2 (en) * 2002-04-12 2008-03-11 Boston Scientific Scimed, Inc. Occlusive composition
WO2004039425A1 (fr) * 2002-10-29 2004-05-13 Toray Industries, Inc. Materiau d'embolisation vasculaire
HUP0203719A2 (en) * 2002-10-31 2007-09-28 Stepan Dr Gudak Polyuretan composition for fillin blood vessels and method of aplication of it
US20040115164A1 (en) * 2002-12-17 2004-06-17 Pierce Ryan K. Soft filament occlusive device delivery system
ES2326648T3 (es) * 2003-03-07 2009-10-16 Micro Therapeutics, Inc. Composiciones para uso en la embolizacion de vasos sanguineos que comprenden altos niveles de agente de contraste.
US20050209674A1 (en) * 2003-09-05 2005-09-22 Kutscher Tuvia D Balloon assembly (V)
US20050090804A1 (en) * 2003-10-22 2005-04-28 Trivascular, Inc. Endoluminal prosthesis endoleak management
US20050283182A1 (en) * 2004-06-21 2005-12-22 Concentric Medical, Inc. Systems and methods for intraluminal delivery of occlusive elements
EP3085362B1 (fr) 2005-05-09 2021-01-13 Biosphere Medical, S.A. Compositions et procédés utilisant des microsphères et des agents de contraste non ioniques
EP1951129B1 (fr) 2005-10-19 2012-11-21 Pulsar Vascular, Inc. Procedes et systemes d'agrafage et de reparation par voie endovasculaire d'anomalies dans des lumieres ou des tissus
US8545530B2 (en) * 2005-10-19 2013-10-01 Pulsar Vascular, Inc. Implantable aneurysm closure systems and methods
ATE520427T1 (de) * 2006-01-30 2011-09-15 Biosphere Medical Inc Poröse intravaskuläre embolisierungsteilchen und verfahren zu deren herstellung
WO2007090127A2 (fr) 2006-01-30 2007-08-09 Surgica Corporation Particules d'embolisation intravasculaire compressible, procedes connexes et systemes d'administration
US7442105B2 (en) * 2006-05-05 2008-10-28 Freleng Safety Products, Llc Personal visibility marker
US9642693B2 (en) * 2007-04-13 2017-05-09 W. L. Gore & Associates, Inc. Medical apparatus and method of making the same
US9717584B2 (en) * 2007-04-13 2017-08-01 W. L. Gore & Associates, Inc. Medical apparatus and method of making the same
US20080255678A1 (en) * 2007-04-13 2008-10-16 Cully Edward H Medical apparatus and method of making the same
WO2010028314A1 (fr) 2008-09-05 2010-03-11 Pulsar Vascular, Inc. Systèmes et procédés pour soutenir ou fermer une ouverture ou cavité physiologique
US20110212179A1 (en) * 2008-10-30 2011-09-01 David Liu Micro-spherical porous biocompatible scaffolds and methods and apparatus for fabricating same
EP2805680B1 (fr) 2009-09-04 2017-10-25 Pulsar Vascular, Inc. Systèmes de fermeture d´ouverture anatomique
EP2713905B1 (fr) 2011-06-03 2022-03-16 Pulsar Vascular, Inc. Systèmes pour fermer une ouverture anatomique, comprenant des dispositifs d'anévrisme absorbant les chocs
CN103582460B (zh) 2011-06-03 2019-03-19 帕尔萨维斯库勒公司 具有额外锚固机构的动脉瘤装置以及相关系统及方法
US9119625B2 (en) 2011-10-05 2015-09-01 Pulsar Vascular, Inc. Devices, systems and methods for enclosing an anatomical opening
EP2846706A1 (fr) 2012-05-10 2015-03-18 Pulsar Vascular, Inc. Dispositifs d'anévrisme à extrémité spirale
CN102764456B (zh) * 2012-07-24 2014-10-15 上海交通大学 血管栓塞剂及其用途、制备方法
CN111840265B (zh) * 2019-04-29 2023-06-16 李学义 一种乙醇类硬化剂及其应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2160503A (en) * 1936-02-14 1939-05-30 Chemische Forschungs Gmbh Blood stancher
US2657201A (en) * 1949-11-25 1953-10-27 Du Pont Controlled, heterogeneous hydrolysis of polymeric esters
FR2053037B1 (fr) * 1969-06-27 1974-08-09 Nyegaard & Co As
DE2909439A1 (de) * 1979-03-08 1980-09-18 Schering Ag Neue nichtionische roentgenkontrastmittel
US4631188A (en) * 1983-08-31 1986-12-23 S.K.Y. Polymers, Ltd. (Kingston Technologies) Injectable physiologically-acceptable polymeric composition
US4739768B2 (en) * 1986-06-02 1995-10-24 Target Therapeutics Inc Catheter for guide-wire tracking
GB8900376D0 (en) * 1989-01-09 1989-03-08 Nycomed As Iodinated esters
US5202352A (en) * 1990-08-08 1993-04-13 Takeda Chemical Industries, Ltd. Intravascular embolizing agent containing angiogenesis-inhibiting substance
US5690666A (en) * 1992-11-18 1997-11-25 Target Therapeutics, Inc. Ultrasoft embolism coils and process for using them
US5443454A (en) * 1992-12-09 1995-08-22 Terumo Kabushiki Kaisha Catheter for embolectomy
WO1996004954A1 (fr) * 1994-08-17 1996-02-22 Boston Scientific Corporation Implant, et procede et dispositf d'implantation
US5749894A (en) * 1996-01-18 1998-05-12 Target Therapeutics, Inc. Aneurysm closure method
US5702361A (en) * 1996-01-31 1997-12-30 Micro Therapeutics, Inc. Method for embolizing blood vessels

Similar Documents

Publication Publication Date Title
WO1998016265B1 (fr) Agents embolisants liquides contenant de l'acetate de polyvinyle partiellement hydrolyse
DE69826452T2 (de) Stellenspezifische proteinmodifizierung
EP2347770B2 (fr) Procédé de production d' une préparation pharmaceutique injectable
CA2060652A1 (fr) Derives a groupe n-(substituant) cycloalkyl et polycycloalkyl trp-, phe- et phenethylamine, substitue en alpha
US4054736A (en) Clathrate compounds of prostaglandins or their analogues with cyclodextrin
CA2198917A1 (fr) Liberation prolongee de peptides depuis des compositions pharmaceutiques
CH619614A5 (fr)
CH629475A5 (de) Verfahren zur herstellung von polypeptiden.
DE59010706D1 (de) Gallensäurederivate, Verfahren zu ihrer Herstellung, Verwendung als Arzneimittel
ATE49886T1 (de) Neue galenische zubereitungsformen von oralen antidiabetika und verfahren zu ihrer herstellung.
CA2212856A1 (fr) Composes contenant du benzopyranne et techniques d'application
TW329386B (en) Cough medicine
IE881017L (en) Novel 2ß-morpholino-androstane derivatives and processes for¹their preparation
Chatt et al. Chemical evidence concerning the function of molybdenum in nitrogenase
WO1996001634B1 (fr) Compositions a base d'oxytretracycline a action prolongee
DE69001734T2 (de) Aeusserlich anzuwendende amusulosin enthaltende arzneizubereitung.
EP0383346A3 (fr) Catalyseur, procédé pour le préparer et procédé de polymérisation d'oléfines utilisant ce catalyseur
Colonna et al. Large scale HELP synthesis of oligodeoxynucleotides by the hydroxybenzotriazole phosphotriester approach.
CA2249753A1 (fr) Procede ameliore de synthese d'alkyl-polyglucosides
WO2001032680A3 (fr) 18-nor-steroides utilises comme oestrogenes a effet selectif
WO1999005103A3 (fr) Derives d'amidino-camptothecine
ATE30231T1 (de) 3-beta-(3'-(carboxypropionyloxy))-ursa-9(11),12 dien-28-carbonsaeure sowie ihre salze, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel.
US4368138A (en) Water soluble thymidine derivative
EP0361317A3 (fr) Dérivés de pyridoindole et leur procédé de préparation
US4389414A (en) Prostaglandin compositions